CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 80 filers reported holding CATALYST BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,561 | +31.3% | 46,778 | -4.3% | 0.00% | – |
| Q2 2023 | $17,185 | +28.1% | 48,878 | -24.6% | 0.00% | – |
| Q1 2023 | $13,413 | +9.8% | 64,799 | +179.7% | 0.00% | – |
| Q4 2022 | $12,220 | -49.1% | 23,166 | -52.3% | 0.00% | – |
| Q3 2022 | $24,000 | -14.3% | 48,560 | +646.2% | 0.00% | – |
| Q2 2021 | $28,000 | – | 6,508 | +17977.8% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 36 | -99.6% | 0.00% | – |
| Q2 2020 | $55,000 | +77.4% | 9,368 | +32.0% | 0.00% | – |
| Q1 2020 | $31,000 | +416.7% | 7,095 | +688.3% | 0.00% | – |
| Q4 2019 | $6,000 | +100.0% | 900 | +28.6% | 0.00% | – |
| Q3 2019 | $3,000 | -66.7% | 700 | -17.6% | 0.00% | – |
| Q3 2018 | $9,000 | -71.0% | 849 | -30.1% | 0.00% | – |
| Q1 2018 | $31,000 | – | 1,215 | +20150.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 6 | -98.7% | 0.00% | – |
| Q2 2017 | $2,000 | – | 458 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
| 22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
| Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
| Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
| Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
| AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
| Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
| Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |